Go to the list of all blogs
Anna G's Avatar
published in Blogs
Jun 01, 2023
Incyte Corp (INCY, $62.58) Faces Downtrend: Analyzing Shareholder Returns and Economic Performance

Incyte Corp (INCY, $62.58) Faces Downtrend: Analyzing Shareholder Returns and Economic Performance

Are you ready to embrace the future of trading? Tickeron's AI robots empower investors to make smarter decisions.

Β 

Incyte Corp (INCY, $62.58) finds itself in the midst of a bearish trend, as indicated by A.I.dvisor's prediction of a potential Downtrend continuation. Shareholders have endured a challenging period, with a notable 38% decline in share price over the past three years and an additional 19% drop in the last quarter. To gain a comprehensive understanding of the company's current situation, it is essential to examine the correlation between shareholder returns and Incyte's underlying economics.

Over the past three years, while the broader market has returned approximately 40%, shareholders of Incyte have faced a contrasting experience with a significant decline of 38%. This divergence raises questions about the company's economic performance and its ability to generate returns for its shareholders.

Delving deeper into Incyte's economic performance, it becomes crucial to analyze whether the company's financials align with the disappointing shareholder returns. By scrutinizing key indicators, such as revenue growth, profitability, and efficiency, we can shed light on the underlying factors contributing to the company's stock performance.

Incyte Corp's economic performance has a critical role to play in determining its future prospects. By assessing the correlation between shareholder returns and the company's financial metrics, we can better understand whether there are any disparities or potential catalysts that may drive a turnaround. This analysis provides valuable insights for investors seeking to navigate the evolving landscape of Incyte Corp and make informed decisions regarding their investment strategy.

It is essential to approach Incyte Corp's current bearish trend with a comprehensive understanding of its underlying economics and the factors influencing its share price. By staying informed and aware of the correlation between shareholder returns and the company's financial performance, investors can make more informed decisions about their investment in Incyte and evaluate its future potential.

Β 

Related Ticker: INCY

INCY in upward trend: 10-day moving average broke above 50-day moving average on April 22, 2026

The 10-day moving average for INCY crossed bullishly above the 50-day moving average on April 22, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 61 cases where INCY's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on May 04, 2026. You may want to consider a long position or call options on INCY as a result. In of 101 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

INCY moved above its 50-day moving average on May 01, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where INCY advanced for three days, in of 323 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 233 cases where INCY Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where INCY declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

INCY broke above its upper Bollinger Band on May 06, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. INCY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.475) is normal, around the industry mean (32.569). P/E Ratio (13.811) is within average values for comparable stocks, (52.494). Projected Growth (PEG Ratio) (0.359) is also within normal values, averaging (1.715). Dividend Yield (0.000) settles around the average of (0.033) among similar stocks. P/S Ratio (3.700) is also within normal values, averaging (337.864).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. INCY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

Notable companies

The most notable companies in this group are Regeneron Pharmaceuticals (NASDAQ:REGN), Incyte Corp (NASDAQ:INCY), Moderna (NASDAQ:MRNA), Exelixis (NASDAQ:EXEL), Arrowhead Pharmaceuticals (NASDAQ:ARWR), Nektar Therapeutics (NASDAQ:NKTR), Sarepta Therapeutics (NASDAQ:SRPT), Novavax (NASDAQ:NVAX), Inovio Pharmaceuticals (NASDAQ:INO), Cel-Sci Corp (ASE:CVM).

Industry description

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

Market Cap

The average market capitalization across the Biotechnology Industry is 2.22B. The market cap for tickers in the group ranges from 58 to 107.87B. VRTX holds the highest valuation in this group at 107.87B. The lowest valued company is SEELQ at 58.

High and low price notable news

The average weekly price growth across all stocks in the Biotechnology Industry was 2%. For the same Industry, the average monthly price growth was 7%, and the average quarterly price growth was 14%. CNSP experienced the highest price growth at 228%, while RLFTY experienced the biggest fall at -89%.

Volume

The average weekly volume growth across all stocks in the Biotechnology Industry was 17%. For the same stocks of the Industry, the average monthly volume growth was 15% and the average quarterly volume growth was 41%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 82
Price Growth Rating: 53
SMR Rating: 92
Profit Risk Rating: 93
Seasonality Score: 8 (-100 ... +100)
View a ticker or compare two or three
INCY
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of drugs

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
1801 Augustine Cut-Off
Phone
+1 302 498-6700
Employees
2844
Web
https://www.incyte.com
Interact to see
Advertisement
Tickeron, a global innovator in AI-powered financial technology, has launched its groundbreakingΒ AI Trend Prediction Engine (TPE)Β β€” a state-of-the-art platform that provides unmatched precision in short-term stock trend forecasting.
#artificial_intelligence
In the fast-paced world of financial markets, where milliseconds can mean millions, artificial intelligence has emerged as the ultimate game-changer.
Tickeron, a global innovator inΒ AI-powered trading solutions, has announced outstanding results from itsΒ 5-minute AI Trading AgentΒ focused onΒ HUBB,Β AVGO,Β ITA, andΒ QQQ. In justΒ 36 days, the agent achieved aΒ 70% win rate, generatingΒ $3,439 in closed trade profitsΒ and a remarkableΒ +40% annualized return.
SoFi Technologies, Inc. has staged one of 2025’s most remarkable rallies, climbing 248.8% from its April 7 low of $8.60 to close at $30.00 on October 27.
#artificial_intelligence
Tickeron, a pioneer in AI-driven financial innovation, has unveiled outstanding results from its 5-minute AI Trading Agent focused on seven top-performing assets: Broadcom (AVGO), Alphabet (GOOGL), Hubbell (HUBB), Ingersoll Rand (IR), iShares U.S. Aerospace & Defense ETF (ITA), NVIDIA (NVDA), and SPDR S&P Aerospace & Defense ETF (XAR).
#artificial_intelligence
Tickeron, a global innovator inΒ AI-powered trading solutions, has announced outstanding results from itsΒ 5-minute AI Trading AgentΒ focused onΒ HUBB,Β AVGO,Β ITA, andΒ QQQ. In justΒ 36 days, the agent achieved aΒ 70% win rate, generatingΒ $3,439 in closed trade profitsΒ and a remarkableΒ +40% annualized return.
AMD’s 235% surge in 2025 marks its transformation from a PC chipmaker into a major AI infrastructure powerhouse. With partnerships from OpenAI to Oracle and cutting-edge Instinct accelerators, AMD is emerging as NVIDIA’s top challengerβ€”and a prime opportunity for AI-driven traders.
#artificial_intelligence
GE Aerospace’s 93% surge in 2025 highlights its transformation into a powerhouse of commercial and defense aviation. With record profits, soaring demand for jet engines, and strong aftermarket revenues, GE is flying higher than ever β€” and AI trading tools are helping investors capture the momentum.
#artificial_intelligence
In this article, we examine how traders and investors can leverage AI-driven trading robots alongside inverse exchange-traded funds (ETFs)β€”with a spotlight on the semiconductor-bear ETFΒ SOXSβ€”to maintain profitability during market downturns.
#artificial_intelligence#trading
In today’s volatile financial landscape, where market downturns can swiftly erode portfolio value, AI-powered trading robots are becoming essential tools for modern investors. As of November 5, 2025, global markets face mounting uncertainty amid geopolitical tensions and evolving monetary policies.
#artificial_intelligence
Palantir Technologies, Inc. has delivered one of the most impressive runs in the tech sector in 2025, soaring 193% from its April 7 low of $66.12 to the November 10 close at $193.61, after setting fresh all-time highs of $207.52 earlier in the month.
Tickeron, a leader in AI-driven financial technology, has reported outstanding results for its 15-minuteΒ AI Trading AgentΒ targetingΒ SoFi Technologies, Inc. (SOFI). Over just 94 days, the agent delivered anΒ annualized return of +105%, demonstrating how machine learning can turn volatility into opportunity.
Amid a turbulent market dominated by bearish semiconductor momentum, Tickeron’s AI-driven trading robots have achieved standout profitability by leveraging the Direxion Daily Semiconductor Bear 3X Shares (SOXS) ETF. As the PHLX Semiconductor Index declines, these smart agents convert market downturns into profitable opportunities.
#artificial_intelligence#trading
As Apple's stock continues to attract investors amid its innovative product releases, AI-powered tools are emerging to enhance trading strategies for AAPL. Tickeron's AI Trading Double Agent, specifically tailored for the AAPL/SOXS pair on a 15-minute timeframe, exemplifies this trend. This sophisticated robot employs machine learning and financial learning models to dynamically switch between bullish positions in AAPL and bearish positions in SOXS (Direxion Daily Semiconductor Bear 3x Shares), leveraging the inverse correlation to optimize returns in volatile markets.
#artificial_intelligence
Jiade Limited’s stock just hit a 3-month low, but new AI tools from Tickeron reveal hidden opportunities beneath the volatility. Discover JDZG’s fundamentals, recent performance, and how AI-powered trading systems can help investors navigate this fast-changing edtech stock.
Rigetti’s stock continues its sharp decline, but cutting-edge AI trading robots from Tickeron help traders navigate the volatility with precision. Discover how automated hedging, real-time signals, and high-accuracy Financial Learning Models (FLMs) can turn RGTI’s unpredictable swings into strategic opportunities.
Home Depot pushes innovation in 2025 with award-winning appliances, smart safety tools, and seasonal decor, blending tech and sustainabilityβ€”while facing earnings challenges and AI trading opportunities.
Baidu faces a bearish technical shift as its MACD Histogram turns negativeβ€”an 82% historically confirmed signal of short-term downside. Yet despite market pressure, Baidu’s 2025 AI breakthroughs and Tickeron’s advanced trading robots create unique opportunities for traders to hedge volatility, capitalize on momentum, and navigate the stock’s uncertain path with precision.